Patients and individuals
Understand approved information, prepare questions and follow authorized next steps through a guided digital experience. Sensitive information remains subject to identity, consent and access controls.
AXIONOVA™ connects approved systems, data and care workflows in a governed enterprise environment. ALETHRA™ controls identity, permissions, evidence and authorized actions. ALETHA™ helps patients and teams understand information and navigate the experience, while clinical decisions remain with qualified practitioners.
Explore ALETHRA™’s broader sovereign AI infrastructure at alethra.com.
Hi, I am ALETHA. I help you understand information, prepare questions and navigate authorized next steps. Your practitioner makes the clinical decisions.
ALETHRA™ governs the system. ALETHA™ guides the experience.
Build on the systems and equipment your institution already uses. AXIONOVA™ connects approved information and workflows; ALETHRA™ governs who can access them, what can proceed and what must be reviewed. Each deployment is configured around your systems, roles and jurisdiction.
AXIONOVA™ALETHRA™
Consent, access permissions and evidence context travel with the information. Institutional oversight does not grant unrestricted access to every individual’s record. Clinical actions remain subject to the applicable professional authority and approvals.
From the first interaction to ongoing follow-up, authorized information supports continuity without removing the decisions that belong to the patient, practitioner or institution.
The information stays connected. Clinical authority stays with qualified practitioners.
Different users need different views, permissions and responsibilities. ALETHRA™ maintains those boundaries while ALETHA™ makes the experience easier to navigate.
Understand approved information, prepare questions and follow authorized next steps through a guided digital experience. Sensitive information remains subject to identity, consent and access controls.
Review relevant evidence and source context, see where information is incomplete or uncertain, and coordinate care within professional and institutional permissions.
Oversee authorized workflows, access controls, service responsibilities and audit records. Operational oversight remains separate from unrestricted access to individual clinical information.
One governed environment. Distinct responsibilities. Clear accountability.
ALETHRA™ applies a consistent governance framework across people, devices, compounds, protocols and data streams. These controls establish the conditions under which an action can proceed.
Verify the person, device, module or governed entity associated with an interaction.
Check the action against role, protocol, consent and jurisdiction. Actions outside the authorized scope are refused.
Preserve material events with their time, source and authorization context. Record corrections as linked events rather than silently overwriting the original history.
Distinguish measured observations, calculated values and model-derived insights. Keep provenance and uncertainty visible.
Route high-risk decisions to qualified human review. Clinical decisions, diagnoses and prescriptions remain with independent licensed practitioners.
ALETHRA™ governs the conditions of access and action across the AXIONOVA™ ecosystem. Each technology retains its own clinical, operational and deployment requirements.
Connect biological and diagnostic context with source provenance and evidence boundaries to support practitioner review. Associations and predispositions do not become diagnoses or treatment instructions.
Explore AXIOPATHSVerify Closed Drug Modules, refuse unauthorized or mismatched administrations and bind governed events to the record.
Explore AXISPreserve verified molecular identity and package access history within the governed evidence record.
Explore AXIOGOVBind the device to its wearer, scope capture to consent and assess signal confidence before presenting information as insight.
Explore AGIS PROBind the kit to the individual’s identity and consent, and govern access to the resulting information.
Explore the testOrder lab tests from the platform and have samples collected at home. Results come back to your record.
Explore AXIOLABSMaintain prescription and authorization boundaries around governed compounds and their protocols.
Explore compoundsKeep each published development tied to its sources and evidence context, so editorial content informs without becoming clinical advice.
Explore SIGNALExplain approved information, guide the experience and route requests within the boundaries ALETHRA™ enforces.
Explore ALETHAThe same governance principles support different care environments. Scope, interfaces and workflows are configured for the institution rather than imposed as a one-size-fits-all replacement.
Connect approved clinical and operational information across teams, with role-based access, traceable handoffs and clear review responsibilities.
Bring diagnostic, biomarker and longitudinal information into context for practitioner-led programs, patient education and ongoing review.
Align authorized information, patient guidance and workflow coordination around the clinic’s defined services and professional responsibilities.
Apply a shared governance framework across locations while maintaining site-specific permissions, integration requirements and jurisdictional controls.
Deployment begins with your priorities, existing infrastructure and the workflows that matter most. Activation proceeds through a defined scope, verified connections and agreed acceptance criteria.
Agree the initial outcomes, systems, roles, data boundaries and responsibilities.
Configure approved interfaces and test information flows, permissions, exceptions and evidence handling.
Release the agreed workflows, prepare teams and establish support and escalation routes.
Review performance, maintain controls and extend the deployment through agreed additions.
The digital platform and ALETHA™ experience are available 24/7. Human clinical coverage, emergency response and physical services follow their applicable service arrangements.
The deployment is designed to build on approved existing systems and equipment. Interfaces, data availability and workflow requirements are assessed and validated for the agreed scope.
No. ALETHA™ guides the experience and explains approved information within its authorized scope. Clinical decisions, diagnoses and prescriptions remain with qualified licensed practitioners. AXIONOVA™ does not practice medicine.
A shared enterprise framework can support multiple locations, with site-specific permissions, integrations, data requirements and jurisdictional controls defined for each activation.
Access is registration-based and qualification-gated. Identity, role, consent, purpose and the applicable jurisdiction determine what each user can see and do. Material events and refusals are recorded for authorized review.
Begin with a deployment discussion to define priorities, existing systems and the first set of workflows. Integration scope, responsibilities and acceptance criteria are then established together.
Bring your institution’s approved information, people and workflows into a connected environment governed by ALETHRA™ and guided by ALETHA™.
AXIONOVA™ connects. ALETHRA™ governs. ALETHA™ guides.